235 related articles for article (PubMed ID: 33757676)
1. Biochemical diagnosis of Cushing's disease: Screening and confirmatory testing.
Petersenn S
Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101519. PubMed ID: 33757676
[TBL] [Abstract][Full Text] [Related]
2. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
[TBL] [Abstract][Full Text] [Related]
3. Cushing's Syndrome: Screening and Diagnosis.
Ceccato F; Boscaro M
High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):209-15. PubMed ID: 27160717
[TBL] [Abstract][Full Text] [Related]
4. Overnight 1 mg dexamethasone suppression test and 24 h urine free cortisol-accuracy and pitfalls when screening for Cushing's syndrome.
Petersenn S
Pituitary; 2022 Oct; 25(5):693-697. PubMed ID: 35821308
[TBL] [Abstract][Full Text] [Related]
5. Concordance of the late night salivary cortisol in patients with Cushing's syndrome and elevated urine-free cortisol.
Doi SA; Clark J; Russell AW
Endocrine; 2013 Apr; 43(2):327-33. PubMed ID: 23238876
[TBL] [Abstract][Full Text] [Related]
6. Screening Tests for Cushing's Syndrome: Urinary Free Cortisol Role Measured by LC-MS/MS.
Ceccato F; Barbot M; Zilio M; Frigo AC; Albiger N; Camozzi V; Antonelli G; Plebani M; Mantero F; Boscaro M; Scaroni C
J Clin Endocrinol Metab; 2015 Oct; 100(10):3856-61. PubMed ID: 26274344
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of late-night salivary cortisol for diagnosis of subclinical Cushing's syndrome.
Kuzu I; Zuhur SS; Demir N; Aktas G; Yener Ozturk F; Altuntas Y
Endokrynol Pol; 2016; 67(5):487-492. PubMed ID: 26884297
[TBL] [Abstract][Full Text] [Related]
8. Pitfalls in the diagnosis and management of Cushing's syndrome.
Bansal V; El Asmar N; Selman WR; Arafah BM
Neurosurg Focus; 2015 Feb; 38(2):E4. PubMed ID: 25639322
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Pitfalls in Cushing Disease: Surgical Remission Rates, Test Thresholds, and Lessons Learned in 105 Patients.
Mallari RJ; Thakur JD; Barkhoudarian G; Eisenberg A; Rodriguez A; Rettinger S; Cohan P; Nieman L; Kelly DF
J Clin Endocrinol Metab; 2022 Jan; 107(1):205-218. PubMed ID: 34478542
[TBL] [Abstract][Full Text] [Related]
10. The 10:00-11:00 pm urine cortisol/creatinine ratio. An alternative to late-night salivary cortisol for the diagnosis of Cushing's syndrome.
Bruno OD; Rossi MA; Juárez-Allen L; Serra HA; Albiero MC
Medicina (B Aires); 2015; 75(6):373-8. PubMed ID: 26707659
[TBL] [Abstract][Full Text] [Related]
11. Late-night salivary cortisol as a screening test for Cushing's syndrome.
Raff H; Raff JL; Findling JW
J Clin Endocrinol Metab; 1998 Aug; 83(8):2681-6. PubMed ID: 9709931
[TBL] [Abstract][Full Text] [Related]
12. Update on late-night salivary cortisol for the diagnosis of Cushing's syndrome: methodological considerations.
Raff H
Endocrine; 2013 Oct; 44(2):346-9. PubMed ID: 23839587
[TBL] [Abstract][Full Text] [Related]
13. Specificity of screening tests for Cushing's syndrome in an overweight and obese population.
Baid SK; Rubino D; Sinaii N; Ramsey S; Frank A; Nieman LK
J Clin Endocrinol Metab; 2009 Oct; 94(10):3857-64. PubMed ID: 19602562
[TBL] [Abstract][Full Text] [Related]
14. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
Castro M; Elias LL; Elias PC; Moreira AC
Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing's syndrome.
Belaya ZE; Iljin AV; Melnichenko GA; Rozhinskaya LY; Dragunova NV; Dzeranova LK; Butrova SA; Troshina EA; Dedov II
Endocrine; 2012 Jun; 41(3):494-500. PubMed ID: 22447310
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of late-night and post-overnight dexamethasone suppression salivary cortisone for the investigation of Cushing's syndrome.
Ng CM; Lam TK; Au Yeung YC; Choi CH; Iu YP; Shek CC; Tiu SC
Hong Kong Med J; 2017 Dec; 23(6):570-8. PubMed ID: 29026058
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study.
Ceccato F; Marcelli G; Martino M; Concettoni C; Brugia M; Trementino L; Michetti G; Arnaldi G
J Endocrinol Invest; 2019 Mar; 42(3):327-335. PubMed ID: 29987756
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Aron DC; Raff H; Findling JW
J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease.
Amlashi FG; Swearingen B; Faje AT; Nachtigall LB; Miller KK; Klibanski A; Biller BM; Tritos NA
J Clin Endocrinol Metab; 2015 Oct; 100(10):3770-7. PubMed ID: 26196950
[TBL] [Abstract][Full Text] [Related]
20. UTILITY OF A SINGLE LATE-NIGHT PLASMA CORTISOL AND ACTH FOR THE DIAGNOSIS OF CUSHING SYNDROME.
Jarial KDS; Bhansali A; Mukherjee KK; Pal R; Sharma A; Vashishtha RK; Sukumar SP; Sachdeva N; Walia R
Endocr Pract; 2018 Feb; 24(2):156-162. PubMed ID: 29144801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
